Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Electrode tab for secondary battery and secondary battery using the same
Real-time RSL monitoring in a web-based application
Maize variety inbred PH1CD7
Piezoelectric ultrasonic transducer apparatus
Distributed IP-PBX signal processing
Measurement and uses of oxidative status
  Randomly Featured Patents
Refrigeration air conditioning system
Methods and apparatus for overdrive pacing heart tissue using an implantable cardiac stimulation device
Clock generating circuit and clock generating method
Four-sided electrical contact
Processor for forms with multi-format data
Fabricated cowl for double annular combustor of a gas turbine engine
Test system for conducting a function test of a semiconductor element on a wafer, and operating method
Manual tool for application of a tile laying device and similar articles on a surface to coat
Method for automatic depth control for earth moving and grading
Manually operated photographic processing system